Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. [PDF]
, 2000 David R. Owens +4 more
openalex +1 more source
Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog
Clinical Medicine Insights: Endocrinology and Diabetes, 2010 Insulin detemir is a long-acting basal insulin approved for use in patients with type 1 (T1DM) or type 2 diabetes (T2DM). Insulin detemir has demonstrated equivalent glycemic control and hypoglycemic risk when compared to insulin glargine, and insulin ...
Jason R. Young, Carrie Mcadam-Marx
doaj +1 more source
Modeling the distribution of insulin in pancreas [PDF]
arXivMaintenance of adequate physical and functional pancreatic $\beta$-cell mass is critical for the prevention or delay of diabetes mellitus. It is well established that insulin potently activates mitogenic and anti-apoptotic signaling cascades in cultured $\beta$-cells.
arxiv
Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety. [PDF]
, 2000 John B. Buse
openalex +1 more source
Diabetes, Metabolic Syndrome and Obesity, 2011 Shinya Abe1,2, Gaku Inoue1,2, Satoru Yamada1,3, Junichiro Irie1,3, Hiroyuki Nojima2, Kaoru Tsuyusaki2, Kensuke Usui2, Koichiro Atsuda2, Toshikazu Yamanouchi41Diabetes Center, Kitasato Institute Hospital, 2Center for Clinical Pharmacy and Clinical ...
Abe S +8 more
doaj
DIETS: Diabetic Insulin Management System in Everyday Life [PDF]
arXivPeople with diabetes need insulin delivery to effectively manage their blood glucose levels, especially after meals, because their bodies either do not produce enough insulin or cannot fully utilize it. Accurate insulin delivery starts with estimating the nutrients in meals and is followed by developing a detailed, personalized insulin injection ...
arxiv
Insulin glargine in the treatment of type 1 and type 2 diabetes 59
Vascular Health and Risk Management, 2006 Anthony H BarnettBirmingham Heartlands Hospital, Birmingham, West Midlands, England, UKAbstract: Insulin glargine is an analogue of human insulin that is modified to provide a consistent level of plasma insulin over a long duration.
Anthony H Barnett
doaj
Intravenous Glargine and Regular Insulin Have Similar Effects on Endogenous Glucose Output and Peripheral Activation/Deactivation Kinetic Profiles [PDF]
, 2002 Sunder Mudaliar +7 more
openalex +1 more source
Prospective Audit of the Introduction of Insulin Glargine (Lantus) Into Clinical Practice in Type 1 Diabetic Patients [PDF]
, 2003 Ian Gallen, Celia Carter
openalex +1 more source
Cancer mortality and insulin glargine [PDF]
Journal of Diabetes, 2009 Yehuda Handelsman +1 more
openaire +2 more sources